Cobalt (II, III) oxide nanoparticles (Co3O4-NPs) can be potentially used in different technological and medical applications, including drug delivery or as possible anticancer therapeutic tool [1][2].
In this study, we report genotoxicity of 10-30 nm and <50 nm cobalt oxide nanoparticles to human lymphocyte cultures in vitro. The genotoxicity tests used in this study were Comet assay, cytokinesis-block micronucleus (CBMN) assay and analysis of sister-chromatid exchange (SCE). Human lymphocytes obtained from 5 donors were treated with Co3O4-NPs at concentrations of 20-80 μg/ml in comet assay and no clear dose-response relationship was found. However, individual donor sensitivity was observed. Lymphocytes from three donors were sensitive to DNA damaging action of Co3O4–NPs, lymphocytes of two donors were insensitive. In CBMN assay, lymphocytes from three donors showed dose-dependent increase (up to 40 μg/ml) in the frequency of micronucleated cells, treated with 10-30 and <50 nm size Co3O4-NPs. In SCE analysis, lymphocytes from two out of three donors showed dose-dependent increase of DNA damage, treated with 10-30 nm size of Co3O4-NPs. No correlation between SCE and concentration of <50 nm size Co3O4-NPs was observed. What is more, in most cases, <50 nm NPs induced more DNA damage, compared to 10-30 nm NPs.
Taken together all results of our study, it could be concluded that Co3O4-NPs are genotoxic in human lymphocytes in vitro, at least for some donors and in some assays. This raises concern about safety of use of Co3O4-NPs and requires thorough genotoxicity analysis of Co3O4-NPs in different cell cultures.